Cure Ventures
Drew King has extensive work experience in various roles and companies. Drew is currently working at Cure Ventures as a Partner and Chief Financial Officer, starting in May 2021. Before that, they worked at Bain Capital as a Vice President from April 2012 to May 2021. Prior to that, Drew worked at Ernst & Young as a Manager from May 2005 to March 2012.
Drew King has a Master of Science (MS) degree in Accounting from the University of Virginia. Prior to that, they obtained a Bachelor of Science (BS) degree in Corporate Finance & Accounting from Bentley University. However, there is no available information about their degree and field of study from Regent's University London. Additionally, Drew King holds a Certified Public Accountant certification from the Massachusetts Board of Public Accountancy and a Series 3 certification (inactive) from the National Futures Association.
Cure Ventures
Cure Ventures is a venture firm focused on investing in the life sciences and medical technologies. We aim to propel novel cures to market by discovering and enabling biotechnology, pharmaceutical, medical device, and medtech firms with exceptional growth potential committed to addressing unmet medical needs for global patient targets.